Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146M Buy
+669,647
New +$149M 0.37% 52
2025
Q4
Sell
-1,129,511
Closed -$262M 1729
2025
Q3
$262M Buy
1,129,511
+21,802
+2% +$4.44M 0.63% 23
2025
Q2
$206M Buy
1,107,709
+3,589
+0.3% +$667K 0.56% 26
2025
Q1
$231M Sell
1,104,120
-42,430
-4% -$8.25M 0.72% 21
2024
Q4
$204M Buy
1,146,550
+54,501
+5% +$10M 0.56% 26
2024
Q3
$216M Buy
1,092,049
+409,214
+60% +$76.4M 0.65% 20
2024
Q2
$117M Sell
682,835
-147,918
-18% -$24.5M 0.35% 51
2024
Q1
$151M Sell
830,753
-241,488
-23% -$41.6M 0.48% 39
2023
Q4
$166M Buy
1,072,241
+52,489
+5% +$7.65M 0.59% 31
2023
Q3
$152M Buy
1,019,752
+126,654
+14% +$18.6M 0.62% 28
2023
Q2
$120M Sell
893,098
-177,367
-17% -$26M 0.49% 44
2023
Q1
$171M Sell
1,070,465
-322,730
-23% -$49.3M 0.72% 25
2022
Q4
$225M Sell
1,393,195
-39,488
-3% -$6.05M 1.09% 15
2022
Q3
$192M Buy
1,432,683
+213,127
+17% +$30.6M 1% 13
2022
Q2
$187M Buy
1,219,556
+449,340
+58% +$68.7M 0.93% 18
2022
Q1
$125M Buy
770,216
+203,722
+36% +$29.6M 0.49% 46
2021
Q4
$76.7M Buy
566,494
+196,338
+53% +$23.2M 0.25% 101
2021
Q3
$39.9M Sell
370,156
-420,874
-53% -$48.1M 0.15% 167
2021
Q2
$89.1M Buy
791,030
+22,976
+3% +$2.59M 0.16% 147
2021
Q1
$83.1M Sell
768,054
-177,524
-19% -$19M 0.17% 148
2020
Q4
$532M Sell
945,578
-358,154
-27% -$34.4M 0.23% 111
2020
Q3
$114M Sell
1,303,732
-1,391,142
-52% -$131M 0.34% 73
2020
Q2
$265M Buy
2,694,874
+1,958,276
+266% +$172M 0.88% 22
2020
Q1
$56.1M Buy
736,598
+197,289
+37% +$16.8M 0.47% 40
2019
Q4
$47.8M Sell
539,309
-105,174
-16% -$8.73M 0.3% 69
2019
Q3
$48.8M Buy
644,483
+44,101
+7% +$3.02M 0.36% 56
2019
Q2
$43.7M Buy
600,382
+38,200
+7% +$3M 0.34% 61
2019
Q1
$45.3M Buy
562,182
+267,193
+91% +$21.9M 0.37% 55
2018
Q4
$27.2M Sell
294,989
-72,772
-20% -$6.4M 0.3% 76
2018
Q3
$34.8M Buy
367,761
+115,494
+46% +$11M 0.26% 96
2018
Q2
$23.4M Sell
252,267
-534,170
-68% -$52.2M 0.2% 136
2018
Q1
$74.4M Sell
786,437
-167,512
-18% -$18.4M 0.69% 21
2017
Q4
$92.3M Sell
953,949
-377,714
-28% -$35.6M 0.79% 18
2017
Q3
$118M Buy
1,331,663
+857,603
+181% +$65.3M 1.07% 12
2017
Q2
$34.4M Sell
474,060
-10,236
-2% -$688K 0.33% 70
2017
Q1
$31.6M Sell
484,296
-69,931
-13% -$4.4M 0.28% 80
2016
Q4
$34.7M Buy
554,227
+169,353
+44% +$10.3M 0.34% 63
2016
Q3
$24.3M Buy
384,874
+119,209
+45% +$7.72M 0.29% 80
2016
Q2
$16.4M Buy
265,665
+24,186
+10% +$1.47M 0.24% 103
2016
Q1
$13.8M Sell
241,479
-51,417
-18% -$2.87M 0.23% 99
2015
Q4
$17.4M Sell
292,896
-53,883
-16% -$3.1M 0.32% 77
2015
Q3
$18.9M Sell
346,779
-71,133
-17% -$4.63M 0.38% 65
2015
Q2
$28.1M Sell
417,912
-31,305
-7% -$2.04M 0.36% 71
2015
Q1
$26.3M Buy
449,217
+9,742
+2% +$589K 0.34% 83
2014
Q4
$28.8M Buy
439,475
+361,503
+464% +$22.8M 0.34% 66
2014
Q3
$4.5M Sell
77,972
-235,132
-75% -$13.1M 0.16% 181
2014
Q2
$17.7M Sell
313,104
-20,000
-6% -$1.05M 0.2% 117
2014
Q1
$17.1M Sell
333,104
-133,759
-29% -$6.76M 0.27% 81
2013
Q4
$24.7M Sell
466,863
-24,453
-5% -$1.2M 0.37% 60
2013
Q3
$22M Buy
491,316
+27,001
+6% +$1.2M 0.35% 61
2013
Q2
$19.2M Buy
+464,315
New +$20.3M 0.36% 63

Other funds holding ABBV

KBC Group's ABBV Position: Q1 2026 in Review

KBC Group opened a new position in AbbVie (ABBV) in Q1 2026: 669,647 shares worth $146M. The stake represents 0.37% of the portfolio and ranks #52 among its holdings. This is a return to the name: KBC Group previously reported a position in ABBV as recently as Q3 2025.

KBC Group first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $532M in Q4 2020. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • KBC Group held 669,647 shares of AbbVie worth $146M as of Q1 2026.
  • AbbVie was a new KBC Group position in Q1 2026.
  • AbbVie made up 0.37% of KBC Group's portfolio in Q1 2026, its #52 holding.
  • KBC Group first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • KBC Group's AbbVie position peaked at $532M in Q4 2020.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.